Free Trial

Best Biotechnology Stocks

Biotech stocks are investments in companies that develop products and technologies based on biological research, primarily aimed at advancing healthcare, agriculture, and environmental solutions. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

This list includes the largest market-cap stocks in the biotechnology field. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceP/E RatioMarket CapVolumeAverage VolumeIndicator(s)
AbbVie Inc. stock logo
ABBV
AbbVie
$193.40
-0.9%
80.58$342.11 billion5.82 million6.08 millionEarnings Report
Analyst Forecast
Analyst Revision
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$419.88
-2.1%
25.40$158.50 billion2.77 million1.76 millionAnalyst Forecast
Insider Trade
Short Interest ↑
Analyst Revision
Danaher Co. stock logo
DHR
Danaher
$196.90
-1.2%
37.29$140.92 billion3.69 million3.37 millionInsider Trade
Short Interest ↑
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$498.86
-2.1%
N/A$128.25 billion1.45 million1.34 millionUpcoming Earnings
Analyst Revision
Positive News
GSK plc stock logo
GSK
GSK
$38.75
-2.8%
24.37$79.94 billion4.45 million4.75 millionEarnings Report
Analyst Upgrade
News Coverage
Cencora, Inc. stock logo
COR
Cencora
$290.46
-0.8%
41.32$56.32 billion1.10 million1.52 millionUpcoming Earnings
Analyst Forecast
Positive News
Takeda Pharmaceutical Company Limited stock logo
TAK
Takeda Pharmaceutical
$15.03
-1.7%
37.56$47.81 billion1.67 million1.87 millionUpcoming Earnings
News Coverage
Positive News
argenx SE stock logo
ARGX
argenx
$639.90
-0.8%
N/A$39.07 billion181,899308,708Upcoming Earnings
Positive News
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
$232.21
-0.6%
57.34$38.02 billion750,2621.08 millionPositive News
Cognizant Technology Solutions Co. stock logo
CTSH
Cognizant Technology Solutions
$75.23
+2.3%
16.68$37.21 billion7.36 million3.61 millionEarnings Report
Dividend Announcement
Analyst Forecast
News Coverage
Positive News
Gap Up
High Trading Volume
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$255.13
-3.1%
N/A$33.19 billion1.52 million884,831Earnings Report
Analyst Downgrade
Positive News
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$151.02
-2.6%
20.14$26.63 billion1.84 million1.44 millionUpcoming Earnings
BioNTech SE stock logo
BNTX
BioNTech
$102.43
-1.7%
N/A$24.58 billion984,983912,192Upcoming Earnings
International Flavors & Fragrances Inc. stock logo
IFF
International Flavors & Fragrances
$77.91
-0.7%
82.89$19.93 billion1.73 million1.53 millionUpcoming Earnings
Analyst Revision
Royalty Pharma plc stock logo
RPRX
Royalty Pharma
$32.48
-1.0%
22.40$18.72 billion2.61 million3.26 millionUpcoming Earnings
Positive News
United Therapeutics Co. stock logo
UTHR
United Therapeutics
$293.85
-3.0%
12.91$13.20 billion427,109444,938Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
Positive News
Illumina, Inc. stock logo
ILMN
Illumina
$76.51
-1.4%
N/A$12.11 billion1.34 million2.29 millionUpcoming Earnings
Analyst Forecast
Positive News
ICON Public Limited stock logo
ICLR
ICON Public
$145.21
-4.1%
15.24$11.73 billion4.00 million970,655Earnings Report
Analyst Downgrade
Short Interest ↓
Gap Down
High Trading Volume
Suzano S.A. stock logo
SUZ
Suzano
$8.79
-0.8%
13.94$11.63 billion1.17 million2.00 millionUpcoming Earnings
News Coverage
Positive News
Revvity, Inc. stock logo
RVTY
Revvity
$92.95
-0.5%
42.06$11.17 billion1.73 million929,647Earnings Report
Dividend Announcement
Analyst Forecast
Analyst Revision
News Coverage
Moderna, Inc. stock logo
MRNA
Moderna
$27.03
-5.3%
N/A$10.45 billion14.88 million7.43 millionEarnings Report
News Coverage
High Trading Volume
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$302.25
-2.0%
23.93$8.69 billion436,225342,213Insider Trade
Short Interest ↑
Fabrinet stock logo
FN
Fabrinet
$210.93
+2.9%
23.59$7.56 billion477,276614,128Upcoming Earnings
Short Interest ↓
Positive News
Gap Up
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
$45.37
-0.3%
N/A$7.20 billion2.55 million3.01 millionUpcoming Earnings
News Coverage
Positive News
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
$234.41
N/A$6.57 billion1218Earnings Report
Legend Biotech Co. stock logo
LEGN
Legend Biotech
$33.96
-2.8%
N/A$6.24 billion535,3271.23 millionPositive News
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$116.92
-1.4%
779.45$5.74 billion989,978933,764Upcoming Earnings
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$124.88
-1.3%
25.09$5.46 billion1.76 million1.36 million
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$165.69
-2.5%
55.41$4.79 billion257,506295,185Upcoming Earnings
Analyst Forecast
Analyst Revision
News Coverage
Positive News
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
$35.24
-1.7%
N/A$4.54 billion3.85 million1.26 millionUpcoming Earnings
Positive News
High Trading Volume
Lumentum Holdings Inc. stock logo
LITE
Lumentum
$61.52
+4.2%
N/A$4.26 billion2.56 million1.91 millionUpcoming Earnings
Positive News
Gap Up
Bloom Energy Co. stock logo
BE
Bloom Energy
$16.84
-8.1%
N/A$3.88 billion12.34 million6.79 millionEarnings Report
Analyst Forecast
News Coverage
Positive News
Gap Up
Oddity Tech Ltd. stock logo
ODD
Oddity Tech
$63.89
+4.0%
38.96$3.57 billion2.59 million546,430Earnings Report
Analyst Forecast
News Coverage
High Trading Volume
SpringWorks Therapeutics, Inc. stock logo
SWTX
SpringWorks Therapeutics
$46.21
-0.2%
N/A$3.47 billion6.44 million1.90 millionAnalyst Forecast
News Coverage
High Trading Volume
Hercules Capital, Inc. stock logo
HTGC
Hercules Capital
$17.87
-0.2%
11.10$3.14 billion1.27 million1.06 millionEarnings Report
Dividend Cut
Analyst Forecast
News Coverage
Amicus Therapeutics, Inc. stock logo
FOLD
Amicus Therapeutics
$6.68
-13.0%
N/A$2.36 billion10.70 million2.67 millionNews Coverage
Positive News
Gap Down
High Trading Volume
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
$16.06
-3.5%
N/A$2.33 billion1.14 million1.09 millionUpcoming Earnings
Positive News
Twist Bioscience Co. stock logo
TWST
Twist Bioscience
$37.71
-1.6%
N/A$2.25 billion1.18 million979,593Upcoming Earnings
Positive News
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$5.50
-1.6%
N/A$2.21 billion12.87 million12.39 millionUpcoming Earnings
Ascentage Pharma Group International stock logo
AAPG
Ascentage Pharma Group International
$25.15
+2.9%
N/A$2.19 billion6,33273,663Gap Down
What President Trump’s Executive Order 14154 means for your money (Ad)

Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard.

But because of the massive changes impacting U.S. stocks, Tilson has agreed to publish his latest fi
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
$2.49
-0.8%
N/A$2.13 billion3.13 million5.20 millionUpcoming Earnings
Analyst Forecast
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$19.83
-0.5%
N/A$1.99 billion1.61 million1.39 millionUpcoming Earnings
Short Interest ↑
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
$8.71
-1.6%
N/A$1.82 billion3.83 million2.82 millionUpcoming Earnings
Analyst Forecast
Analyst Revision
News Coverage
Apogee Therapeutics, Inc. stock logo
APGE
Apogee Therapeutics
$39.20
-0.1%
N/A$1.77 billion432,048514,434News Coverage
Positive News
Galapagos NV stock logo
GLPG
Galapagos
$26.78
-0.5%
N/A$1.76 billion125,989211,365Options Volume
Standex International Co. stock logo
SXI
Standex International
$144.97
+2.5%
31.65$1.72 billion93,39655,958Earnings Report
Dividend Announcement
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
$23.75
+1.6%
N/A$1.51 billion2.46 million750,124Upcoming Earnings
News Coverage
Positive News
High Trading Volume
Immunocore Holdings plc stock logo
IMCR
Immunocore
$30.15
+0.2%
N/A$1.51 billion105,785432,751Upcoming Earnings
News Coverage
Positive News
Evotec SE stock logo
EVO
Evotec
$4.23
+0.7%
N/A$1.50 billion23,968130,819Upcoming Earnings
Short Interest ↓
Phreesia, Inc. stock logo
PHR
Phreesia
$25.34
+1.5%
N/A$1.49 billion421,166431,331Short Interest ↑
JPMorgan U.S. Tech Leaders ETF stock logo
JTEK
JPMorgan U.S. Tech Leaders ETF
$70.55
+0.7%
33.95$1.45 billion193,370271,115Positive News
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
$11.99
+1.7%
N/A$1.36 billion1.64 million1.56 millionShort Interest ↑
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
$7.94
+2.8%
N/A$1.22 billion2.10 million1.23 millionUpcoming Earnings
Analyst Forecast
Analyst Revision
News Coverage
Azenta, Inc. stock logo
AZTA
Azenta
$26.23
-0.4%
N/A$1.20 billion789,087652,159Upcoming Earnings
Positive News
Tutor Perini Co. stock logo
TPC
Tutor Perini
$22.00
+2.5%
N/A$1.16 billion424,160527,432News Coverage
Gap Up
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$13.74
+1.4%
N/A$1.12 billion605,7091.20 millionUpcoming Earnings
News Coverage
Positive News
Adaptive Biotechnologies Co. stock logo
ADPT
Adaptive Biotechnologies
$7.36
N/A$1.09 billion2.01 million1.49 millionEarnings Report
News Coverage
Positive News
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$3.33
-7.2%
N/A$1.09 billion10.84 million7.63 millionUpcoming Earnings
Positive News
Oaktree Specialty Lending Co. stock logo
OCSL
Oaktree Specialty Lending
$13.27
-7.8%
19.81$1.09 billion2.10 million750,051Earnings Report
Analyst Forecast
News Coverage
Positive News
Gap Down
High Trading Volume
Novavax, Inc. stock logo
NVAX
Novavax
$6.41
-3.9%
N/A$1.03 billion5.62 million8.37 million
10x Genomics, Inc. stock logo
TXG
10x Genomics
$8.10
-2.1%
N/A$990.65 million3.00 million2.26 millionUpcoming Earnings
News Coverage
Positive News
Thermon Group Holdings, Inc. stock logo
THR
Thermon Group
$26.82
+2.2%
19.72$903.57 million138,864168,826Positive News
Zymeworks Inc. stock logo
ZYME
Zymeworks
$12.88
-1.0%
N/A$896.15 million409,671613,850Upcoming Earnings
Analyst Revision
Positive News
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
$14.66
-3.7%
N/A$883.65 million451,684599,000Upcoming Earnings
News Coverage
Positive News
Abrdn Healthcare Investors stock logo
HQH
Abrdn Healthcare Investors
$16.07
-1.0%
N/A$865.56 million204,080185,224Short Interest ↑
SLR Investment Corp. stock logo
SLRC
SLR Investment
$15.31
-1.5%
8.65$847.86 million156,220163,258Upcoming Earnings
Analyst Forecast
Short Interest ↓
News Coverage
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$6.08
-0.7%
N/A$839.43 million906,5361.34 millionNews Coverage
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$7.86
+3.0%
N/A$838.11 million2.85 million1.35 millionUpcoming Earnings
High Trading Volume
Redwire Co. stock logo
RDW
Redwire
$10.92
+1.3%
N/A$825.26 million707,781984,719Short Interest ↑
Gap Up
Avid Bioservices, Inc. stock logo
CDMO
Avid Bioservices
$12.50
+0.1%
N/A$799.18 million3.07 million1.34 millionHigh Trading Volume
Immunome, Inc. stock logo
IMNM
Immunome
$8.86
+0.8%
N/A$770.93 million717,282905,244Positive News
Replimune Group, Inc. stock logo
REPL
Replimune Group
$9.64
-1.4%
N/A$742.43 million651,530871,462Positive News
Transcat, Inc. stock logo
TRNS
Transcat
$79.65
+0.4%
43.05$741.46 million71,73775,217Positive News
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
$21.70
-0.7%
N/A$697.13 million280,459264,406Upcoming Earnings
News Coverage
Positive News
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$33.56
-2.3%
83.90$674.93 million277,993202,197Analyst Upgrade
Insider Trade
Short Interest ↑
Positive News
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
$21.70
-2.3%
N/A$665.47 million345,994591,124Upcoming Earnings
Analyst Forecast
News Coverage
Positive News
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$5.63
+8.1%
N/A$641.01 million1.28 million1.26 millionUpcoming Earnings
Options Volume
Analyst Revision
Capricor Therapeutics Inc stock logo
CAPR
Capricor Therapeutics
$12.74
+0.3%
N/A$581.93 million1.30 million1.51 millionNews Coverage
Positive News
BlackRock TCP Capital Corp. stock logo
TCPC
BlackRock TCP Capital
$6.75
-1.3%
N/A$574.27 million392,617571,616Upcoming Earnings
Analyst Forecast
News Coverage
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
$10.48
+1.7%
N/A$556.38 million316,999252,660Upcoming Earnings
News Coverage
Positive News
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
$6.08
-2.4%
N/A$548.42 million2.05 million1.66 million
Diversified Healthcare Trust stock logo
DHC
Diversified Healthcare Trust
$2.24
-0.9%
N/A$540.37 million550,666990,041Upcoming Earnings
Positive News
UroGen Pharma Ltd. stock logo
URGN
UroGen Pharma
$11.41
-2.0%
N/A$525.93 million534,142533,418Analyst Forecast
Analyst Revision
News Coverage
Arvinas, Inc. stock logo
ARVN
Arvinas
$7.23
-24.8%
N/A$497.22 million16.80 million1.22 millionEarnings Report
Short Interest ↑
News Coverage
Gap Down
High Trading Volume
Prothena Co. plc stock logo
PRTA
Prothena
$8.72
-5.2%
N/A$495.21 million1.94 million507,037Upcoming Earnings
News Coverage
High Trading Volume
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
$9.83
+2.3%
N/A$492.65 million654,047819,760Upcoming Earnings
News Coverage
Positive News
Upstream Bio, Inc. stock logo
UPB
Upstream Bio
$9.00
-2.8%
N/A$483.20 million267,173323,065News Coverage
Positive News
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
$17.85
+3.7%
N/A$458.48 million295,496268,876Analyst Revision
Positive News
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$5.14
+0.6%
N/A$457.89 million1.47 million1.24 millionUpcoming Earnings
ABIVAX Société Anonyme stock logo
ABVX
ABIVAX Société Anonyme
$6.91
-2.9%
N/A$438.23 million100,216131,879Analyst Forecast
News Coverage
Positive News
What President Trump’s Executive Order 14154 means for your money (Ad)

Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard.

But because of the massive changes impacting U.S. stocks, Tilson has agreed to publish his latest fi
Zhengye Biotechnology Holding Limited stock logo
ZYBT
Zhengye Biotechnology
$10.43
+14.5%
N/A$429.68 million424,609295,223
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
$1.90
N/A$428.41 million1.67 million3.30 millionUpcoming Earnings
PureTech Health plc stock logo
PRTC
PureTech Health
$17.66
+2.3%
N/A$424.18 million2,7914,666News Coverage
Positive News
Gap Up
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$1.11
N/A$420.67 million687,1172.19 millionUpcoming Earnings
News Coverage
Rapport Therapeutics stock logo
RAPP
Rapport Therapeutics
$11.47
+0.2%
N/A$418.63 million119,811177,166
Celcuity Inc. stock logo
CELC
Celcuity
$10.80
-3.1%
N/A$408.66 million250,977298,804Short Interest ↓
Analyst Revision
Positive News
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$6.98
-5.2%
N/A$405.31 million957,3061.48 millionUpcoming Earnings
News Coverage
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$10.09
-3.4%
N/A$377.78 million126,215235,096Analyst Revision
News Coverage
Positive News
Gap Up
Abrdn Life Sciences Investors stock logo
HQL
Abrdn Life Sciences Investors
$12.73
-0.8%
N/A$367.40 million105,411101,633Short Interest ↑
Heron Therapeutics, Inc. stock logo
HRTX
Heron Therapeutics
$2.35
-2.9%
N/A$357.98 million1.44 million2.30 millionUpcoming Earnings
News Coverage

More Biotech Resources

For those interested in diving deeper into the biotech sector, here are a couple of valuable resources:

Biotech Stocks Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.